163169-15-1 ((S)-4-TERT-BUTYL-2-[(SP)-2-(DIPHENYLPHOSPHINO)FERROCENYL]-2-OXAZOLINE,[(5Z)-5-[(4S)-4-Tert-butyl-1,3-oxazolidin-3-id-2-ylidene]cyclopenta-1,3-dien-1-yl]-diphenylphosphane;cyclopenta-1,3-diene;iron(2+))

(4S)-叔丁基-(2R)-[2-(二苯基膦基)二茂铁基]-2-噁唑啉;(S,Sp)-(4,5-二氢-4-叔丁基-2-噁唑)-2-(二苯基膦基)二茂铁;(2R)-1-[(4S)-4-(1,1-二甲基乙基)-4,5-二氢-2-噁唑基]-2-(二苯基膦基)二茂铁;1-[(4S)-4-(1,1-二甲基乙基)-4,5-二氢-2-噁唑啉基]-2-(二苯基膦)-,(2R)-;(2S)-1-[(4SP)-4-(1,1-二甲基乙基)-4,5-二氢-2-噁唑基]-2-(二苯基膦基)二茂铁;5-二氢-4-叔丁基-2-噁唑基]-2-(二苯基膦基)二茂铁;(2S)-1-[(4R)-4,5-二氢-4-叔丁基-2-噁唑基]-2-(二苯基膦基)二茂铁;(SP)-1-[(4S)-4-叔丁基-4,5-二氢-2-恶唑基]-2-(二苯基膦)二茂铁;(4S)-叔丁基-(2SP)-[2-(二苯基膦基)二茂铁基]-2-噁唑啉;

(S)-4-TERT-BUTYL-2-[(SP)-2-(DIPHENYLPHOSPHINO)FERROCENYL]-2-OXAZOLINE;Naud ligand SL-N004-2;(S)-4-tert-Butyl-2-[(SP)-2-(diphenylphosphino)ferrocenyl]-2-oxazoline >=97%;Ferrocene, 1-[(4S)-4-(1,1-dimethylethyl)-4,5-dihydro-2-oxazolyl]-2-(diphenylphosphino)-, (2R)-;(2R)-1-[(4S)-4-(1,1-Dimethylethyl)-4,5-dihydro-2-oxazolyl]-2-(diphenylphosphino)ferrocene (acc to CAS);Iron(2+) (2Z,4S)-4-tert-butyl-2-[2-(diphenylphosphanyl)cyclopenta-2,4-dien-1-ylidene]-1,3-oxazolidin-3-ide cyclopenta-2,4-dien-1-ide (1/1/1);Ferrocene, 1-[(4S)-4-(1,1-dimethylethyl)-4,5-dihydro-2-oxazolyl]2-(diphenylphosphino)-, (2R)-;[(5Z)-5-[(4S)-4-Tert-butyl-1,3-oxazolidin-3-id-2-ylidene]cyclopenta-1,3-dien-1-yl]-diphenylphosphane;(2R)-1-[(4S)-4-(1,1-Dimethylethyl)-4,5-dihydro-2-oxazolyl]-2-(diphenylphosphino)ferrocene;(S,Sp)-(4,5-Dihydro-4-tert-butyl-2-oxazolyl)-2-(diphenylphosphino)ferrocene;(2R)-1-[(4S)-4-(1,1-dimethylethyl)-4,5- dihydro-2-oxazolyl]-2-(diphenylphosphino)-Ferrocene;(S,S)-(4,5-Dihydro-4-tert-butyl-2-oxazolyl)-2- (diphenylphosphino)ferrocene;(S,Sp)-tBu-Phosferrox;

MFCD19105639

JTWUNUBQGSFMMO-OUSRXUMRSA-N

1S/C24H25NOP.C5H5.Fe/c1-24(2,3)22-17-26-23(25-22)20-15-10-16-21(20)27(18-11-6-4-7-12-18)19-13-8-5-9-14-19;1-2-4-5-3-1;/h4-16,22H,17H2,1-3H3;1-5H;/q2*-1;+2/b23-20-;;/t22-;;/m1../s1

[Fe+2].P(C1C=CC=CC=1)(C1C=CC=CC=1)C1=CC=C/C/1=C1\[N-][C@H](CO\1)C(C)(C)C.[CH-]1C=CC=C1